Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 136 Records) |
| Query Trace: Disease Progression and TP53[original query] |
|---|
| Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Frontiers in oncology 2022 12 926260. Guan Shasha, Deng Guochao, Sun Jingjie, Han Quanli, Lv Yao, Xue Tianhui, Ding Lijuan, Yang Tongxin, Qian Niansong, Dai Guangh |
| Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| DNA methylation is a comprehensive marker for pediatric adrenocortical tumors. Endocrine-related cancer 2022 8 29 (11): 599-613. Bueno Ana Carolina, da Silva Rui M P, Stecchini Mônica F, Marrero-Gutiérrez Junier, de Almeida E Silva Danillo C, Cardinalli Izilda, Scrideli Carlos Alberto, Junqueira Thais, Molina Carlos A F, Ramalho Fernando Silva, Tucci Silvio, Coeli-Lacchini Fernanda Borchers, Moreira Ayrton Custodio, Ramalho Leandra N Z, Brandalise Silvia, Yunes José Andres, de Castro Margaret, Vêncio Ricardo Zorzetto Nicoliello, Antonini Sonir R |
| Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO precision oncology 2022 08 6 e2100504. Wang Jennifer Rui, Montierth Matthew, Xu Li, Goswami Maitrayee, Zhao Xiao, Cote Gilbert, Wang Wenyi, Iyer Priyanka, Dadu Ramona, Busaidy Naifa L, Lai Stephen Y, Gross Neil D, Ferrarotto Renata, Lu Charles, Gunn Gary Brandon, Williams Michelle D, Routbort Mark, Zafereo Mark E, Cabanillas Maria |
| Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer. Molecular oncology 2022 Jul . Zhang Lanxin, Sun Siwen, Zhao Xiaotian, Liu Jingwen, Xu Yang, Xu Lingzhi, Song Chen, Li Na, Yu Jing, Zhao Shanshan, Yu Peiyao, Fang Fengqi, Xie Jiping, Ji Xuening, Yu Ruoying, Ou Qiuxiang, Zhao Zuowei, Li M |
| Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
| Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. The Prostate 2022 6 82 (13): 1264-1272. Bray Alexander W, Duan Rong, Malalur Pannaga, Drusbosky Leylah M, Gourdin Theodore S, Hill Elizabeth G, Lilly Michael |
| Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia 2022 6 36 (7): 1887-1897. Misund Kristine, Hofste Op Bruinink Davine, Coward Eivind, Hoogenboezem Remco M, Rustad Even Holth, Sanders Mathijs A, Rye Morten, Sponaas Anne-Marit, van der Holt Bronno, Zweegman Sonja, Hovig Eivind, Meza-Zepeda Leonardo A, Sundan Anders, Myklebost Ola, Sonneveld Pieter, Waage Ande |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China. International journal of cancer 2022 5 152 (1): 15-23. Su Chunxia, Zhou Juan, Qiang Huiping, Zhao Jing, Chang Qing, Ji Xianxiu, Li Jiaqi, Xie Mengqing, Chu Tianqi |
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. Therapeutic advances in medical oncology 2022 11 14 17588359221133546. Yu Yongfeng, Ren Yongxin, Fang Jian, Cao Lejie, Liang Zongan, Guo Qisen, Han Sen, Ji Zimei, Wang Ye, Sun Yulan, Chen Yuan, Li Xingya, Xu Hua, Zhou Jianying, Jiang Liyan, Cheng Ying, Han Zhigang, Shi Jianhua, Chen Gongyan, Ma Rui, Fan Yun, Sun Sanyuan, Jiao Longxian, Jia Xiaoyun, Wang Linfang, Lu Puhan, Xu Qian, Luo Xian, Su Weiguo, Lu Sh |
| Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
| Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients. Molecular biology reports 2023 8 . Ayad M Ali, Gaza F Sal |
| Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers 2023 8 15 (15): . Sungun Bang, Dongju Won, Saeam Shin, Kang Su Cho, Jae Won Park, Jongsoo Lee, Young Deuk Choi, Suwan Kang, Seung-Tae Lee, Jong Rak Choi, Hyunho H |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome medicine 2023 7 15 (1): 55. Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A Rejto, Woong-Yang Park, Zhengyan K |
| Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China. Annals of hematology 2023 6 . Rongfeng Fu, Huan Dong, Donglei Zhang, Hu Zhou, Xian Zhang, Yueting Huang, Xiaofan Liu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Xinyue Dai, Renchi Yang, Lei Zha |
| Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer. Breast cancer research and treatment 2023 6 . Tom Wei-Wu Chen, Wen Hsiao, Ming-Shen Dai, Ching-Hung Lin, Dwan-Ying Chang, I-Chun Chen, Ming-Yang Wang, Shu-Han Chang, Shu-Min Huang, Ann-Lii Cheng, Ko-Wen Wu, Kien Thiam Tan, Yen-Shen |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2?+?metastatic breast cancer. Scientific reports 2023 6 13 (1): 9928. Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Pa |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Absence of GSTT1 and polymorphisms in GSTP1 and TP53 are associated with the incidence of acne vulgaris. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 2023 4 29 (4): e13333. Rehmat Ullah, Sher Afgan, Mariyam Akhtar, Muhammad Asif, Muhammad Latif, Rashid Mehmood, Muhammad Naeem, Kiran Zahra, Muhammad Farooq, Mourad Ben Said, Furhan Iqb |
| Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing. Anticancer research 2023 4 43 (5): 1891-1900. Joanna Lopacinska-Joergensen, Douglas V N P Oliveira, Tim Svenstrup Poulsen, Claus K Hoegdall, Estrid V Hoegda |
| NEXT-GENERATION SEQUENCING-BASED GENOMIC PROFILING OF CHILDREN WITH ACUTE MYELOID LEUKEMIA. The Journal of molecular diagnostics : JMD 2023 4 . Szilvia Krizsán, Borbála Péterffy, Bálint Egyed, Tibor Nagy, Endre Sebestyén, Lajos László Hegyi, Zsuzsanna Jakab, Dániel J Erdélyi, Judit Müller, György Péter, Krisztina Csanádi, Krisztián Kállay, Gergely Kriván, Gábor Barna, Gábor Bedics, Irén Haltrich, Gábor Ottóffy, Katalin Csernus, Ágnes Vojcek, Lilla Györgyi Tiszlavicz, Krisztina Mita Gábor, Ágnes Kelemen, Péter Hauser, Zsuzsanna Gaál, István Szegedi, Anikó Ujfalusi, Béla Kajtár, Csongor Kiss, András Matolcsy, Botond Tímár, Gábor Kovács, Donát Alpár, Csaba Böd |
| Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC). Oral oncology 2023 3 139 106358. Economopoulou Panagiota, Spathis Aris, Kotsantis Ioannis, Maratou Eirini, Anastasiou Maria, Moutafi Myrto K, Kirkasiadou Maria, Pantazopoulos Anastasios, Giannakakou Maria, Edelstein Daniel L, Sloane Hillary, Fredebohm Johannes, Jones Frederick S, Kyriazoglou Anastasios, Gavrielatou Niki, Foukas Periklis, Panayiotides Ioannis, Psyrri Aman |
| Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer. Cancer research and treatment 2023 3 . Lee Dae-Won, Lim Yoojoo, Kim Hwang-Phill, Kim Su Yeon, Roh Hanseong, Kang Jun-Kyu, Lee Kyung-Hun, Kim Min Jung, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
| Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 2 178 11-19. Zhang Jiexia, Zhou Ningning, Deng Huojin, Chen Xin, Chen Qunqing, Wang Qiongyao, Sun Lei, Wen Yang, Cao Xiaolong, Luo Zhiqiang, Zhang Jian, Zhu Weiliang, Guo Linla |
| Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 100150. Dogan Snjezana, Xu Bin, Rana Satshil, Chen Hui, Ghossein Ronald A, Berger Michael F, Ho Alan L, Katabi No |
| Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma. Cancers 2023 1 15 (1): . Zhou Maggie, Bui Nam, Rathore Richa, Sudhaman Sumedha, George Giby V, Malashevich Allyson K, Malhotra Meenakshi, Liu Minetta C, Aleshin Alexey, Ganjoo Kristen |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: